Tech Center 1600 • Art Units: 1631
This examiner grants 38% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18034042 | VECTORIZED TNF-ALPHA ANTAGONISTS FOR OCULAR INDICATIONS | Non-Final OA | REGENXBIO INC. |
| 18246087 | NOVEL ENHANCED BASE EDITING OR REVISING FUSION PROTEIN AND USE THEREOF | Non-Final OA | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION |
| 18042726 | VIRAL VECTORS ENCODING GLP-1 RECEPTOR AGONIST FUSIONS AND USES THEREOF IN TREATING METABOLIC DISEASES | Non-Final OA | The Trustees of the University of Pennsylvania |
| 17907229 | INDUCIBLE PROMOTER FOR VIRAL VECTOR PRODUCTION | Non-Final OA | ASKBIO INC. |
| 18262799 | PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE | Non-Final OA | The Trustees of Indiana University |
| 18266951 | CULTURE MATERIAL AND USE THEREOF | Non-Final OA | MITSUI CHEMICALS, INC. |
| 18808041 | MITOCHONDRIA ISOLATION FROM CELLS IN SUSPENSION | Non-Final OA | CELLERGY THERAPEUTICS LTD |
| 18350986 | CELLS AND METHOD OF CELL CULTURE | Non-Final OA | Pfizer Inc. |
| 17766704 | CORTICAL NEURAL PROGENITOR CELLS FROM IPSCS | Final Rejection | Cedars-Sinai Medical Center |
| 18446256 | METHODS OF TREATING OR PREVENTING RESPIRATORY CONDITIONS | Non-Final OA | Mesoblast, Inc. |
| 18228016 | METHOD FOR EXTRACTING EPIDERMAL CELLS | Non-Final OA | Hangzhou Singclean Medical Products Co., Ltd |
| 18019357 | AAV VECTORS ENCODING PARKIN AND USES THEREOF | Non-Final OA | Prevail Therapeutics, Inc. |
| 17766083 | Zinc Finger Protein Transcription Factors for Treatment of Prion Disease | Non-Final OA | Sangamo Therapeutics, Inc. |
| 18258207 | LYOPHILIZED MESENCHYMAL STEM CELLS | Non-Final OA | Habil F KHORAKIWALA |
| 18024646 | Quality Improving Agent for IPS Cells, Method of Producing IPS Cells, IPS Cells, and Composition for Producing IPS Cells | Non-Final OA | ID Pharma Co., Ltd. |
| 18041142 | GENE THERAPY VECTOR EXPRESSING CYP27A1 FOR THE TREATMENT OF CEREBROTENDINOUS XANTHOMATOSIS | Final Rejection | FUNDACION PARA LA INVESTIGACION MEDICA APLICADA |
| 18000072 | GENERATION OF PRIMORDIAL GERM CELLS AND METHODS OF USING THE SAME | Non-Final OA | The Board of Trustees of the Leland Stanfor Junior University |
| 17818493 | TRANSIENT EXPRESSION SYSTEM FOR RNA, FOR COSMETIC USES | Non-Final OA | GEG Tech |
| 17743423 | CHIMERIC ANTIGEN RECEPTOR CELL LIBRARY CARRYING GENE ELEMENT COMBINATION, PREPRATION AND SCREENING METHOD, AND USE THEREOF | Final Rejection | PHARCHOICE THERAPEUTICS INC |
| 17772223 | METHOD AND KIT FOR EXPANDING CIRCULATING TUMOR CELLS EX VIVO, COMPOSITE MATERIAL FILM AND PREPARATION METHOD THEREOF, DRUG TESTING METHOD, AND CRYOPRESERVATION SOLUTION | Non-Final OA | Cancer Free Biotech Ltd. |
| 17633570 | GENETIC MODIFICATION SITE | Final Rejection | ReNeuron Limited |
| 17561389 | METHOD FOR CULTIVATION OF ADHERENT CELLS IN A MULTIPARALLEL BIOREACTOR | Final Rejection | Alachua Government Services, Inc. |
| 17551983 | FOOD PRODUCTS COMPRISING CULTIVATED BOVINE CELLS AND METHODS THEREOF | Final Rejection | GOOD Meat, Inc. |
| 16964624 | SCREENING METHOD FOR ESTROGENIC AND ANTI-ESTROGENIC ACTIVITY | Final Rejection | BUNDESINSTITUT FÜR RISIKOBEWERTUNG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy